Efficacy of a Preparation Based on Calcium Butyrate,
complementary therapy
inflammatory bowel diseases (IBD)
maintaining therapy
mesalamine
mesalazine
short chain fatty acids (SCFAs)
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
26 Oct 2021
26 Oct 2021
Historique:
received:
22
09
2021
revised:
11
10
2021
accepted:
25
10
2021
entrez:
13
11
2021
pubmed:
14
11
2021
medline:
14
11
2021
Statut:
epublish
Résumé
Several compounds based on short chain fatty acids and/or probiotics/prebiotics have shown promising results in the therapy of ulcerative colitis (UC), possibly due to its key role in restoring gut homeostasis as well as intestinal barrier integrity. Here, we investigated the efficacy of a patented preparation based on calcium butyrate,
Identifiants
pubmed: 34768480
pii: jcm10214961
doi: 10.3390/jcm10214961
pmc: PMC8585056
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Dis Colon Rectum. 1990 Oct;33(10):858-62
pubmed: 2209275
Dig Dis Sci. 1993 Oct;38(10):1837-42
pubmed: 8404404
Minerva Gastroenterol Dietol. 2019 Dec;65(4):298-308
pubmed: 31646851
Eur J Clin Invest. 2003 Mar;33(3):244-8
pubmed: 12641543
J Crohns Colitis. 2017 Jun 1;11(6):649-670
pubmed: 28158501
Dis Colon Rectum. 1992 Oct;35(10):923-7
pubmed: 1395977
Diagnostics (Basel). 2021 Jun 15;11(6):
pubmed: 34203609
Aliment Pharmacol Ther. 2008 Jan 15;27(2):104-19
pubmed: 17973645
J Clin Med. 2019 Nov 14;8(11):
pubmed: 31739460
J Immunol Res. 2019 Dec 1;2019:7247238
pubmed: 31886308
Scand J Gastroenterol. 2002 Apr;37(4):458-66
pubmed: 11989838
J Crohns Colitis. 2015 Jan;9(1):50-5
pubmed: 25518048
Inflamm Bowel Dis. 2008 Dec;14(12):1660-6
pubmed: 18623174
Nutrients. 2021 May 01;13(5):
pubmed: 34062869
J Clin Med. 2020 May 02;9(5):
pubmed: 32370274
Cochrane Database Syst Rev. 2020 Mar 4;3:CD007443
pubmed: 32128794
Scand J Gastroenterol. 2018 Feb;53(2):152-157
pubmed: 29189092
Panminerva Med. 2018 Mar;60(1):29-34
pubmed: 29370679
Physiol Rev. 2001 Jul;81(3):1031-64
pubmed: 11427691
J Cell Physiol. 2018 Mar;233(3):2091-2103
pubmed: 28294322
Gastroenterol Clin North Am. 2020 Dec;49(4):689-704
pubmed: 33121689
Am J Gastroenterol. 2008 Aug;103(8):2007-14
pubmed: 18802997
Drugs. 1999 Mar;57(3):383-408
pubmed: 10193690
Curr Gastroenterol Rep. 2020 Oct 12;22(12):57
pubmed: 33044636
Am J Gastroenterol. 2009 Feb;104(2):437-43
pubmed: 19174792
Inflamm Bowel Dis. 2012 Dec;18(12):2218-24
pubmed: 22344983
J Clin Med. 2021 Jun 02;10(11):
pubmed: 34199428
Am J Gastroenterol. 2001 Oct;96(10):2921-8
pubmed: 11693327
Gastroenterology. 1992 Jul;103(1):51-6
pubmed: 1612357
Pharmacol Res. 2020 Oct;160:105075
pubmed: 32653651
Scand J Gastroenterol. 1997 Sep;32(9):920-4
pubmed: 9299672
BMC Gastroenterol. 2020 Feb 13;20(1):35
pubmed: 32054445
Dig Dis Sci. 2018 Jul;63(7):1910-1919
pubmed: 29450747
J Clin Med. 2020 Dec 04;9(12):
pubmed: 33291846
World J Gastroenterol. 2015 May 21;21(19):5985-94
pubmed: 26019464
Front Immunol. 2019 Nov 22;10:2754
pubmed: 31824517
Aliment Pharmacol Ther. 1995 Jun;9(3):309-13
pubmed: 7654893
Minerva Gastroenterol Dietol. 2017 Dec;63(4):373-384
pubmed: 28293937
Intest Res. 2018 Oct;16(4):579-587
pubmed: 30301332